BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//Bioinformatics Software | QIAGEN Digital Insights - ECPv6.15.17.1//NONSGML v1.0//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-ORIGINAL-URL:https://staging.digitalinsights.supremeclients.com
X-WR-CALDESC:Events for Bioinformatics Software | QIAGEN Digital Insights
REFRESH-INTERVAL;VALUE=DURATION:PT1H
X-Robots-Tag:noindex
X-PUBLISHED-TTL:PT1H
BEGIN:VTIMEZONE
TZID:America/Halifax
BEGIN:DAYLIGHT
TZOFFSETFROM:-0400
TZOFFSETTO:-0300
TZNAME:ADT
DTSTART:20230312T060000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0300
TZOFFSETTO:-0400
TZNAME:AST
DTSTART:20231105T050000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:-0400
TZOFFSETTO:-0300
TZNAME:ADT
DTSTART:20240310T060000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0300
TZOFFSETTO:-0400
TZNAME:AST
DTSTART:20241103T050000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:-0400
TZOFFSETTO:-0300
TZNAME:ADT
DTSTART:20250309T060000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0300
TZOFFSETTO:-0400
TZNAME:AST
DTSTART:20251102T050000
END:STANDARD
END:VTIMEZONE
BEGIN:VEVENT
DTSTART;TZID=America/Halifax:20240613T130000
DTEND;TZID=America/Halifax:20240613T140000
DTSTAMP:20260403T191745
CREATED:20240523T052050Z
LAST-MODIFIED:20241024T183044Z
UID:10000765-1718283600-1718287200@staging.digitalinsights.supremeclients.com
SUMMARY:Accelerating Drug Discovery with Comprehensive Curated Knowledge
DESCRIPTION:In the rapidly evolving landscape of drug discovery\, the ability to integrate high-quality research findings into knowledge graphs is paramount. For over twenty years\, the Ingenuity team with QIAGEN has curated these nodes and relationships. Our QIAGEN Biomedical KB-HD make these data available for consumption outside of Ingenuity Pathway Analysis. \nIn this talk\, we will: \n• Explore how to query and leverage this curated data resource to accelerate the drug discovery process.\n• Provide live demonstration of the underlying database Biomedical-HD\n• Show how the Biomedical KB-HD can be rapidly deployed\n• Show how the underlying schema and ontologies could serve as a scaffold for integrating your own research \nOverall\, this demonstration will show the critical role of knowledge graphs in predicting adverse outcomes and toxicity\, highlighting their transformative potential in steering pharmaceutical research and development. \nLearn more about Biomedical KB: https://qiagen.showpad.com/share/GmpIJaN5kRfsHRD5WPwgc
URL:https://staging.digitalinsights.supremeclients.com/webinars-and-events/accelerating-drug-discovery-with-comprehensive-curated-knowledge/
LOCATION:Virtual - Americas - EST\, United States
CATEGORIES:Discovery,Webinar
ATTACH;FMTTYPE=image/jpeg:https://staging.digitalinsights.supremeclients.com/wp-content/uploads/2024/05/S_1212_9_QDI_QDI_BKB_Original_61828_16x9_62947_Large-1200px.jpg
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Halifax:20240618T130000
DTEND;TZID=America/Halifax:20240618T140000
DTSTAMP:20260403T191745
CREATED:20240520T130124Z
LAST-MODIFIED:20241024T183044Z
UID:10000763-1718715600-1718719200@staging.digitalinsights.supremeclients.com
SUMMARY:HGMD Pro in action: Search\, curate and classify genetic variants - Session 2
DESCRIPTION:In this live\, interactive training session\, our technical expert will show you how the Human Gene Mutation Database (HGMD) Professional can help you get better variant data faster.\n\nYou will learn how to:\n• Differentiate between clinically significant variants and variants of unknown significance (VUS)\n• Use batch search vs. advanced search\, including their differences\n• Curate genes using HGMD Pro’s accurate\, up-to-date information\n• Determine the predominant type of genetic variant that occurs in a specific gene to understand the genetic mechanisms underlying associated diseases\n• Additional topics of interest based on registration feedback
URL:https://staging.digitalinsights.supremeclients.com/webinars-and-events/hgmd-pro-in-action-search-curate-and-classify-genetic-variants-session-2/
LOCATION:Virtual - Americas - EST\, United States
CATEGORIES:Clinical,Training
ATTACH;FMTTYPE=image/jpeg:https://staging.digitalinsights.supremeclients.com/wp-content/uploads/2024/05/S_1158_7_QCI_HGMD_GI1185643368-1.jpg
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Halifax:20240618T130000
DTEND;TZID=America/Halifax:20240618T140000
DTSTAMP:20260403T191745
CREATED:20240808T095719Z
LAST-MODIFIED:20241024T182400Z
UID:10000563-1718715600-1718719200@staging.digitalinsights.supremeclients.com
SUMMARY:HGMD Pro in action: Search\, curate and classify genetic variants - Session 2
DESCRIPTION:In this live\, interactive training session\, our technical expert will show you how the Human Gene Mutation Database (HGMD) Professional can help you get better variant data faster.\n\nYou will learn how to:\n• Differentiate between clinically significant variants and variants of unknown significance (VUS)\n• Use batch search vs. advanced search\, including their differences\n• Curate genes using HGMD Pro’s accurate\, up-to-date information\n• Determine the predominant type of genetic variant that occurs in a specific gene to understand the genetic mechanisms underlying associated diseases\n• Additional topics of interest based on registration feedback
URL:https://staging.digitalinsights.supremeclients.com/webinars-and-events/hgmd-pro-in-action-search-curate-and-classify-genetic-variants-session-2-2/
LOCATION:HSMD-screen-grab-2
ATTACH;FMTTYPE=image/jpeg:https://staging.digitalinsights.supremeclients.com/wp-content/uploads/2024/08/S_1158_7_QCI_HGMD_GI1185643368-1.jpg
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Halifax:20240618T130000
DTEND;TZID=America/Halifax:20240618T143000
DTSTAMP:20260403T191745
CREATED:20240606T041818Z
LAST-MODIFIED:20241024T183045Z
UID:10000768-1718715600-1718721000@staging.digitalinsights.supremeclients.com
SUMMARY:Leveraging the QIAGEN Knowledge Graph and causal embeddings for insights into drug repurposing
DESCRIPTION:By connecting diverse entities and relationships\, biomedical knowledge graphs hold the potential to uncover new insights from existing data. This webinar introduces a machine learning-based approach that utilizes causal interactions from the QIAGEN Knowledge Graph to predict novel drug-disease relationships and construct networks that capture relevant supporting evidence. We will present examples that showcase the application of this approach in the context of drug repurposing.
URL:https://staging.digitalinsights.supremeclients.com/webinars-and-events/leveraging-the-qiagen-knowledge-graph-and-causal-embeddings-for-insights-into-drug-repurposing/
LOCATION:Virtual - Americas - EST\, United States
CATEGORIES:Discovery,Webinar
ATTACH;FMTTYPE=image/jpeg:https://staging.digitalinsights.supremeclients.com/wp-content/uploads/2024/05/S_1212_7_QDI_QDI_BKB_Original_59173.jpg
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Halifax:20240618T130000
DTEND;TZID=America/Halifax:20240618T143000
DTSTAMP:20260403T191745
CREATED:20240808T095718Z
LAST-MODIFIED:20241024T182401Z
UID:10000562-1718715600-1718721000@staging.digitalinsights.supremeclients.com
SUMMARY:Leveraging the QIAGEN Knowledge Graph and causal embeddings for insights into drug repurposing
DESCRIPTION:By connecting diverse entities and relationships\, biomedical knowledge graphs hold the potential to uncover new insights from existing data. This webinar introduces a machine learning-based approach that utilizes causal interactions from the QIAGEN Knowledge Graph to predict novel drug-disease relationships and construct networks that capture relevant supporting evidence. We will present examples that showcase the application of this approach in the context of drug repurposing.
URL:https://staging.digitalinsights.supremeclients.com/webinars-and-events/leveraging-the-qiagen-knowledge-graph-and-causal-embeddings-for-insights-into-drug-repurposing-2/
LOCATION:HSMD-screen-grab-2
ATTACH;FMTTYPE=image/jpeg:https://staging.digitalinsights.supremeclients.com/wp-content/uploads/2024/08/S_1212_7_QDI_QDI_BKB_Original_59173-4.jpg
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Halifax:20240620T130000
DTEND;TZID=America/Halifax:20240620T150000
DTSTAMP:20260403T191745
CREATED:20240523T052728Z
LAST-MODIFIED:20241024T183044Z
UID:10000766-1718888400-1718895600@staging.digitalinsights.supremeclients.com
SUMMARY:QIAGEN Ingenuity Pathway Analysis (IPA) for grant writing and publications with new features
DESCRIPTION:QIAGEN Ingenuity Pathway Analysis (IPA) is more than just an analysis program; it can also help you write grants and publications. IPA provides biological insights backed by expert-curated findings and thousands of pre-analyzed multiomics datasets. You can search for existing knowledge on molecules of interest\, build networks and review results from public studies. Or you can identify key pathways\, regulatory molecules and functional changes in your results and see how your data relates to published studies. \nJoin us to learn how to: \n• Search IPA’s vast collection of curated literature and omics data\n• Relate molecules to phenotypes and functions\n• Build your own networks and predict activity changes\n• Explore a library of over 90\,000 precomputed IPA analyses pulled from publicly available studies\n• Format your dataset and set up an analysis\n• Deeply interrogate key Canonical Pathways\n• Predict regulators causing your observed expression changes\n• Contextualize your results by comparing them to internal and public data\n• Generate the necessary tables and figures for your manuscript \nDo you already have an IPA license? Install IPA and start using it now: https://qiagen.showpad.com/share/CBv30blCPKFDUYHRWtAvI \nLearn more about IPA or request a free trial: https://digitalinsights.qiagen.com/products-overview/discovery-insights-portfolio/analysis-and-visualization/qiagen-ipa/
URL:https://staging.digitalinsights.supremeclients.com/webinars-and-events/qiagen-ingenuity-pathway-analysis-ipa-for-grant-writing-and-publications-with-new-features-3/
LOCATION:Virtual - Americas - EST\, United States
CATEGORIES:Discovery,Training
ATTACH;FMTTYPE=image/jpeg:https://staging.digitalinsights.supremeclients.com/wp-content/uploads/2024/05/S_1062_0_IPA_Challenger_029613_16x9_Large-1200px_54798.jpg
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Halifax:20240625T130000
DTEND;TZID=America/Halifax:20240625T143000
DTSTAMP:20260403T191745
CREATED:20240523T053239Z
LAST-MODIFIED:20241024T183045Z
UID:10000767-1719320400-1719325800@staging.digitalinsights.supremeclients.com
SUMMARY:RNA-seq data analysis and interpretation with sankey plot update
DESCRIPTION:For RNA-seq data\, you will learn how to: \n• Import FASTQ files\, cell matrix files and metadata and how to download references\n• Map reads to a reference genome and generate gene and transcript counts and QC reports displaying % mapped reads\, knee plots\, etc.\n• Generate visualizations of results\, such as heatmaps\, differential expression tables\, PCA/PCOA plots\, Venn diagrams\, sankey plot and others\n• Easily customize RNA-seq workflows\n• Export publication-quality graphics\, tables and reports\n• Send differential expression tables to QIAGEN Ingenuity Pathway Analysis directly from QIAGEN CLC Genomics Workbench to analyze and interpret relevant pathways \nLearn more about CLC or request a free trial: https://digitalinsights.qiagen.com/products-overview/discovery-insights-portfolio/analysis-and-visualization/qiagen-clc-workbench-premium/
URL:https://staging.digitalinsights.supremeclients.com/webinars-and-events/rna-seq-data-analysis-and-interpretation-with-sankey-plot-update-2/
LOCATION:Virtual - Americas - EST\, United States
CATEGORIES:Discovery,Training
ATTACH;FMTTYPE=image/jpeg:https://staging.digitalinsights.supremeclients.com/wp-content/uploads/2024/05/S_1004_3_QDI_CLCPHLpackage_Gi537315268_16x9_Medium-720px_51280.jpg
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Halifax:20240627T130000
DTEND;TZID=America/Halifax:20240627T140000
DTSTAMP:20260403T191745
CREATED:20240610T163717Z
LAST-MODIFIED:20241024T183045Z
UID:10000769-1719493200-1719496800@staging.digitalinsights.supremeclients.com
SUMMARY:Benefits of integrating targeted next-generation sequencing (NGS) panels into molecular diagnostics of solid tumors
DESCRIPTION:Variant detection of multiple genes from a single tumor sample requires high-throughput molecular testing. To meet this demand\, targeted next-generation sequencing (NGS) panels are useful in clinical settings for accurate tumor profiling and the identification of essential molecular aberrations for personalized therapies. By focusing only on a subset of genes\, targeted NGS is not only a cost-effective solution\, but can rapidly deliver insights into a tumor molecular profile. \nTo address this challenge\, a clinical research team led by Dr. Michela Bulfoni at the Istituto di Anatomia Patologica designed custom NGS panels\, named “Glioma” and “Routine Diagnostics”\, targeting single nucleotide variations\, insertions/deletions\, fusions\, and copy number variations of tumor-associated essential genes. \nIn this webinar\, attendees will:\nUnderstand the clinical utility of custom-designed NGS panels for accurate tumour diagnosis\nLearn about the design and application of these NGS panels\nGain insights into the cost-effectiveness and high sensitivity of NGS panels in improving sample throughput
URL:https://staging.digitalinsights.supremeclients.com/webinars-and-events/benefits-of-integrating-targeted-next-generation-sequencing-ngs-panels-into-molecular-diagnostics-of-solid-tumors/
LOCATION:Virtual - Americas - EST\, United States
CATEGORIES:Clinical,Webinar
ATTACH;FMTTYPE=image/jpeg:https://staging.digitalinsights.supremeclients.com/wp-content/uploads/2024/05/S_1314_3_QDI_QCI_SampletoInsight_Oncology_GI1388388119.jpg
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Halifax:20240627T130000
DTEND;TZID=America/Halifax:20240627T140000
DTSTAMP:20260403T191745
CREATED:20240808T095718Z
LAST-MODIFIED:20241024T182402Z
UID:10000561-1719493200-1719496800@staging.digitalinsights.supremeclients.com
SUMMARY:Benefits of integrating targeted next-generation sequencing (NGS) panels into molecular diagnostics of solid tumors
DESCRIPTION:Variant detection of multiple genes from a single tumor sample requires high-throughput molecular testing. To meet this demand\, targeted next-generation sequencing (NGS) panels are useful in clinical settings for accurate tumor profiling and the identification of essential molecular aberrations for personalized therapies. By focusing only on a subset of genes\, targeted NGS is not only a cost-effective solution\, but can rapidly deliver insights into a tumor molecular profile. \nTo address this challenge\, a clinical research team led by Dr. Michela Bulfoni at the Istituto di Anatomia Patologica designed custom NGS panels\, named “Glioma” and “Routine Diagnostics”\, targeting single nucleotide variations\, insertions/deletions\, fusions\, and copy number variations of tumor-associated essential genes. \nIn this webinar\, attendees will:\nUnderstand the clinical utility of custom-designed NGS panels for accurate tumour diagnosis\nLearn about the design and application of these NGS panels\nGain insights into the cost-effectiveness and high sensitivity of NGS panels in improving sample throughput
URL:https://staging.digitalinsights.supremeclients.com/webinars-and-events/benefits-of-integrating-targeted-next-generation-sequencing-ngs-panels-into-molecular-diagnostics-of-solid-tumors-2/
LOCATION:HSMD-screen-grab-2
ATTACH;FMTTYPE=image/jpeg:https://staging.digitalinsights.supremeclients.com/wp-content/uploads/2024/08/S_1314_3_QDI_QCI_SampletoInsight_Oncology_GI1388388119-1.jpg
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Halifax:20240709T130000
DTEND;TZID=America/Halifax:20240709T140000
DTSTAMP:20260403T191745
CREATED:20240618T121111Z
LAST-MODIFIED:20241024T183048Z
UID:10000771-1720530000-1720533600@staging.digitalinsights.supremeclients.com
SUMMARY:QIAGEN Ingenuity Pathway Analysis (IPA) summer camp - Session#1
DESCRIPTION:Join us for three 60-minute training sessions for QIAGEN Ingenuity Pathway Analysis (IPA). \n  \nIn this training\, you’ll learn how to: \n  \nTuesday July 9 – Session#1: 1pm ET/10am PT \n\nIPA general overview\nUpload your dataset (RNA-seq\, scRNA-seq\, proteomics\, metabolomics and more)\nSet up core/pathway analysis in IPA\n\n  \nWednesday July 10 – Session#2: 1pm ET/10am PT \n\nUnderstand the different result types produced (pathways\, key regulators\, and more)\nCustomize chart outputs using filters and different chart types like a volcano plot like bubble chart\n\n  \nThursday July 11 – Session#3: 1pm ET/10am PT \n\nCompare different experimental conditions (different ‘omics data\, treatments\, time points\, single-cell clusters\, disease types and more) and identify similarities and contrasts\nGenerate a network even without a dataset or experimental design for hypothesis generation\n\n  \nIf you are able to attend\, then we will have additional scientists on the call for Q&A. If you are unable to attend\, registering will still allow you to view the recordings.
URL:https://staging.digitalinsights.supremeclients.com/webinars-and-events/qiagen-ingenuity-pathway-analysis-ipa-summer-camp/
LOCATION:Virtual - Americas - EST\, United States
CATEGORIES:Discovery,Event
ATTACH;FMTTYPE=image/jpeg:https://staging.digitalinsights.supremeclients.com/wp-content/uploads/2024/05/S_1233_1_QDI_QDI_IPA_AOP_16x9_63871_Large-1200px.jpg
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Halifax:20240709T130000
DTEND;TZID=America/Halifax:20240709T140000
DTSTAMP:20260403T191745
CREATED:20240808T095717Z
LAST-MODIFIED:20241024T182412Z
UID:10000560-1720530000-1720533600@staging.digitalinsights.supremeclients.com
SUMMARY:QIAGEN Ingenuity Pathway Analysis (IPA) summer camp - Session#1
DESCRIPTION:Join us for three 60-minute training sessions for QIAGEN Ingenuity Pathway Analysis (IPA). \n  \nIn this training\, you’ll learn how to: \n  \nTuesday July 9 – Session#1: 1pm ET/10am PT \n\nIPA general overview\nUpload your dataset (RNA-seq\, scRNA-seq\, proteomics\, metabolomics and more)\nSet up core/pathway analysis in IPA\n\n  \nWednesday July 10 – Session#2: 1pm ET/10am PT \n\nUnderstand the different result types produced (pathways\, key regulators\, and more)\nCustomize chart outputs using filters and different chart types like a volcano plot like bubble chart\n\n  \nThursday July 11 – Session#3: 1pm ET/10am PT \n\nCompare different experimental conditions (different ‘omics data\, treatments\, time points\, single-cell clusters\, disease types and more) and identify similarities and contrasts\nGenerate a network even without a dataset or experimental design for hypothesis generation\n\n  \nIf you are able to attend\, then we will have additional scientists on the call for Q&A. If you are unable to attend\, registering will still allow you to view the recordings.
URL:https://staging.digitalinsights.supremeclients.com/webinars-and-events/qiagen-ingenuity-pathway-analysis-ipa-summer-camp-2/
LOCATION:HSMD-screen-grab-2
ATTACH;FMTTYPE=image/jpeg:https://staging.digitalinsights.supremeclients.com/wp-content/uploads/2024/08/S_1233_1_QDI_QDI_IPA_AOP_16x9_63871_Large-1200px-5.jpg
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Halifax:20240710T130000
DTEND;TZID=America/Halifax:20240710T140000
DTSTAMP:20260403T191745
CREATED:20240618T121620Z
LAST-MODIFIED:20241024T183048Z
UID:10000772-1720616400-1720620000@staging.digitalinsights.supremeclients.com
SUMMARY:QIAGEN Ingenuity Pathway Analysis (IPA) summer camp - Session#2
DESCRIPTION:Join us for three 60-minute training sessions for QIAGEN Ingenuity Pathway Analysis (IPA). \n  \nIn this training\, you’ll learn how to: \n  \nTuesday July 9 – Session#1: 1pm ET/10am PT \n\nIPA general overview\nUpload your dataset (RNA-seq\, scRNA-seq\, proteomics\, metabolomics and more)\nSet up core/pathway analysis in IPA\n\n  \nWednesday July 10 – Session#2: 1pm ET/10am PT \n\nUnderstand the different result types produced (pathways\, key regulators\, and more)\nCustomize chart outputs using filters and different chart types like a volcano plot like bubble chart\n\n  \nThursday July 11 – Session#3: 1pm ET/10am PT \n\nCompare different experimental conditions (different ‘omics data\, treatments\, time points\, single-cell clusters\, disease types and more) and identify similarities and contrasts\nGenerate a network even without a dataset or experimental design for hypothesis generation\n\n  \nIf you are able to attend\, then we will have additional scientists on the call for Q&A. If you are unable to attend\, registering will still allow you to view the recordings.
URL:https://staging.digitalinsights.supremeclients.com/webinars-and-events/qiagen-ingenuity-pathway-analysis-ipa-summer-camp-session2/
LOCATION:Virtual - Americas - EST\, United States
CATEGORIES:Discovery,Event
ATTACH;FMTTYPE=image/jpeg:https://staging.digitalinsights.supremeclients.com/wp-content/uploads/2024/05/S_1233_1_QDI_QDI_IPA_AOP_16x9_63871_Large-1200px.jpg
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Halifax:20240710T130000
DTEND;TZID=America/Halifax:20240710T140000
DTSTAMP:20260403T191745
CREATED:20240808T095716Z
LAST-MODIFIED:20241024T182413Z
UID:10000559-1720616400-1720620000@staging.digitalinsights.supremeclients.com
SUMMARY:QIAGEN Ingenuity Pathway Analysis (IPA) summer camp - Session#2
DESCRIPTION:Join us for three 60-minute training sessions for QIAGEN Ingenuity Pathway Analysis (IPA). \n  \nIn this training\, you’ll learn how to: \n  \nTuesday July 9 – Session#1: 1pm ET/10am PT \n\nIPA general overview\nUpload your dataset (RNA-seq\, scRNA-seq\, proteomics\, metabolomics and more)\nSet up core/pathway analysis in IPA\n\n  \nWednesday July 10 – Session#2: 1pm ET/10am PT \n\nUnderstand the different result types produced (pathways\, key regulators\, and more)\nCustomize chart outputs using filters and different chart types like a volcano plot like bubble chart\n\n  \nThursday July 11 – Session#3: 1pm ET/10am PT \n\nCompare different experimental conditions (different ‘omics data\, treatments\, time points\, single-cell clusters\, disease types and more) and identify similarities and contrasts\nGenerate a network even without a dataset or experimental design for hypothesis generation\n\n  \nIf you are able to attend\, then we will have additional scientists on the call for Q&A. If you are unable to attend\, registering will still allow you to view the recordings.
URL:https://staging.digitalinsights.supremeclients.com/webinars-and-events/qiagen-ingenuity-pathway-analysis-ipa-summer-camp-session2-2/
LOCATION:HSMD-screen-grab-2
ATTACH;FMTTYPE=image/jpeg:https://staging.digitalinsights.supremeclients.com/wp-content/uploads/2024/08/S_1233_1_QDI_QDI_IPA_AOP_16x9_63871_Large-1200px-6.jpg
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Halifax:20240711T130000
DTEND;TZID=America/Halifax:20240711T140000
DTSTAMP:20260403T191745
CREATED:20240618T121756Z
LAST-MODIFIED:20241024T183048Z
UID:10000773-1720702800-1720706400@staging.digitalinsights.supremeclients.com
SUMMARY:QIAGEN Ingenuity Pathway Analysis (IPA) summer camp - Session#3
DESCRIPTION:Join us for three 60-minute training sessions for QIAGEN Ingenuity Pathway Analysis (IPA). \n  \nIn this training\, you’ll learn how to: \n  \nTuesday July 9 – Session#1: 1pm ET/10am PT \n\nIPA general overview\nUpload your dataset (RNA-seq\, scRNA-seq\, proteomics\, metabolomics and more)\nSet up core/pathway analysis in IPA\n\n  \nWednesday July 10 – Session#2: 1pm ET/10am PT \n\nUnderstand the different result types produced (pathways\, key regulators\, and more)\nCustomize chart outputs using filters and different chart types like a volcano plot like bubble chart\n\n  \nThursday July 11 – Session#3: 1pm ET/10am PT \n\nCompare different experimental conditions (different ‘omics data\, treatments\, time points\, single-cell clusters\, disease types and more) and identify similarities and contrasts\nGenerate a network even without a dataset or experimental design for hypothesis generation\n\n  \nIf you are able to attend\, then we will have additional scientists on the call for Q&A. If you are unable to attend\, registering will still allow you to view the recordings.
URL:https://staging.digitalinsights.supremeclients.com/webinars-and-events/qiagen-ingenuity-pathway-analysis-ipa-summer-camp-session3/
LOCATION:Virtual - Americas - EST\, United States
CATEGORIES:Discovery,Event
ATTACH;FMTTYPE=image/jpeg:https://staging.digitalinsights.supremeclients.com/wp-content/uploads/2024/05/S_1233_1_QDI_QDI_IPA_AOP_16x9_63871_Large-1200px.jpg
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Halifax:20240711T130000
DTEND;TZID=America/Halifax:20240711T140000
DTSTAMP:20260403T191745
CREATED:20240808T095716Z
LAST-MODIFIED:20241024T182415Z
UID:10000558-1720702800-1720706400@staging.digitalinsights.supremeclients.com
SUMMARY:QIAGEN Ingenuity Pathway Analysis (IPA) summer camp - Session#3
DESCRIPTION:Join us for three 60-minute training sessions for QIAGEN Ingenuity Pathway Analysis (IPA). \n  \nIn this training\, you’ll learn how to: \n  \nTuesday July 9 – Session#1: 1pm ET/10am PT \n\nIPA general overview\nUpload your dataset (RNA-seq\, scRNA-seq\, proteomics\, metabolomics and more)\nSet up core/pathway analysis in IPA\n\n  \nWednesday July 10 – Session#2: 1pm ET/10am PT \n\nUnderstand the different result types produced (pathways\, key regulators\, and more)\nCustomize chart outputs using filters and different chart types like a volcano plot like bubble chart\n\n  \nThursday July 11 – Session#3: 1pm ET/10am PT \n\nCompare different experimental conditions (different ‘omics data\, treatments\, time points\, single-cell clusters\, disease types and more) and identify similarities and contrasts\nGenerate a network even without a dataset or experimental design for hypothesis generation\n\n  \nIf you are able to attend\, then we will have additional scientists on the call for Q&A. If you are unable to attend\, registering will still allow you to view the recordings.
URL:https://staging.digitalinsights.supremeclients.com/webinars-and-events/qiagen-ingenuity-pathway-analysis-ipa-summer-camp-session3-2/
LOCATION:HSMD-screen-grab-2
ATTACH;FMTTYPE=image/jpeg:https://staging.digitalinsights.supremeclients.com/wp-content/uploads/2024/08/S_1233_1_QDI_QDI_IPA_AOP_16x9_63871_Large-1200px-7.jpg
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Halifax:20240717T130000
DTEND;TZID=America/Halifax:20240717T143000
DTSTAMP:20260403T191745
CREATED:20240618T122221Z
LAST-MODIFIED:20241024T183049Z
UID:10000774-1721221200-1721226600@staging.digitalinsights.supremeclients.com
SUMMARY:De novo assembly\, BLAST and genome finishing with QIAGEN CLC Genomics Workbench
DESCRIPTION:Description \nThis webinar will introduce users to the tools available for short reads (Illumina) as well as long reads (Oxford Nanopore\, Pac Bio) de novo assembly in CLC Genomics Workbench. It will also go over other useful functionalities such as BLAST and genome finishing. \n  \nParticipants will learn the following: \n  \no Download and install needed plugins. \no Import data required for the analysis. \no Run the de novo assembly workflow. \no For long reads\, improve a de novo assembly by polishing with short\, high-quality reads. \no Map reads to a reference and visualize an assembly. \no For long reads\, correct raw long reads for further analysis. \no Use BLAST to investigate the contigs. \no Analyze and assemble contigs through Genome Finishing tools.
URL:https://staging.digitalinsights.supremeclients.com/webinars-and-events/de-novo-assembly-blast-and-genome-finishing-with-qiagen-clc-genomics-workbench/
LOCATION:Virtual - Americas - EST\, United States
CATEGORIES:Discovery,Training
ATTACH;FMTTYPE=image/jpeg:https://staging.digitalinsights.supremeclients.com/wp-content/uploads/2024/05/S_1109_4_QDI_CLC_Challenger_Or55819-1.jpg
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Halifax:20240717T130000
DTEND;TZID=America/Halifax:20240717T143000
DTSTAMP:20260403T191745
CREATED:20240808T095715Z
LAST-MODIFIED:20241024T182416Z
UID:10000557-1721221200-1721226600@staging.digitalinsights.supremeclients.com
SUMMARY:De novo assembly\, BLAST and genome finishing with QIAGEN CLC Genomics Workbench
DESCRIPTION:Description \nThis webinar will introduce users to the tools available for short reads (Illumina) as well as long reads (Oxford Nanopore\, Pac Bio) de novo assembly in CLC Genomics Workbench. It will also go over other useful functionalities such as BLAST and genome finishing. \n  \nParticipants will learn the following: \n  \no Download and install needed plugins. \no Import data required for the analysis. \no Run the de novo assembly workflow. \no For long reads\, improve a de novo assembly by polishing with short\, high-quality reads. \no Map reads to a reference and visualize an assembly. \no For long reads\, correct raw long reads for further analysis. \no Use BLAST to investigate the contigs. \no Analyze and assemble contigs through Genome Finishing tools.
URL:https://staging.digitalinsights.supremeclients.com/webinars-and-events/de-novo-assembly-blast-and-genome-finishing-with-qiagen-clc-genomics-workbench-2/
LOCATION:HSMD-screen-grab-2
ATTACH;FMTTYPE=image/jpeg:https://staging.digitalinsights.supremeclients.com/wp-content/uploads/2024/08/S_1109_4_QDI_CLC_Challenger_Or55819-1-1.jpg
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Halifax:20240718T130000
DTEND;TZID=America/Halifax:20240718T143000
DTSTAMP:20260403T191745
CREATED:20240618T122524Z
LAST-MODIFIED:20241024T183049Z
UID:10000775-1721307600-1721313000@staging.digitalinsights.supremeclients.com
SUMMARY:Antimicrobial resistance (AMR) and multi-locus sequence typing (MLST) with QIAGEN CLC Genomics Workbench
DESCRIPTION:You asked for it by popular demand\, and we’re here to deliver. In this training\, we’ll cover how antimicrobial resistance (AMR) is used for isolation or can be easily integrated with other functionalities such as multi-locus sequence typing (MLST). \nIn this training\, we’ll cover: \n\nIntroduction to AMR\, MLST and relevant databases\nQIAGEN Microbial Insight - Antimicrobial Resistance database (QMI-AR)\nImporting data and downloading needed databases\nFinding resistance with nucleotide DB\, PointFinder and ShortBRED\nIntegrating AMR with MLST\nExporting high-resolution graphics and result tables.
URL:https://staging.digitalinsights.supremeclients.com/webinars-and-events/antimicrobial-resistance-amr-and-multi-locus-sequence-typing-mlst-with-qiagen-clc-genomics-workbench/
LOCATION:Virtual - Americas - EST\, United States
CATEGORIES:Discovery,Training
ATTACH;FMTTYPE=image/jpeg:https://staging.digitalinsights.supremeclients.com/wp-content/uploads/2024/05/S_1108_8_QDI_CLC_Challenger_Or54963_16x9_56810_Large-1200px-2.jpg
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Halifax:20240718T130000
DTEND;TZID=America/Halifax:20240718T143000
DTSTAMP:20260403T191745
CREATED:20240808T095715Z
LAST-MODIFIED:20241024T182417Z
UID:10000556-1721307600-1721313000@staging.digitalinsights.supremeclients.com
SUMMARY:Antimicrobial resistance (AMR) and multi-locus sequence typing (MLST) with QIAGEN CLC Genomics Workbench
DESCRIPTION:You asked for it by popular demand\, and we’re here to deliver. In this training\, we’ll cover how antimicrobial resistance (AMR) is used for isolation or can be easily integrated with other functionalities such as multi-locus sequence typing (MLST). \nIn this training\, we’ll cover: \n\nIntroduction to AMR\, MLST and relevant databases\nQIAGEN Microbial Insight - Antimicrobial Resistance database (QMI-AR)\nImporting data and downloading needed databases\nFinding resistance with nucleotide DB\, PointFinder and ShortBRED\nIntegrating AMR with MLST\nExporting high-resolution graphics and result tables.
URL:https://staging.digitalinsights.supremeclients.com/webinars-and-events/antimicrobial-resistance-amr-and-multi-locus-sequence-typing-mlst-with-qiagen-clc-genomics-workbench-2/
LOCATION:HSMD-screen-grab-2
ATTACH;FMTTYPE=image/jpeg:https://staging.digitalinsights.supremeclients.com/wp-content/uploads/2024/08/S_1108_8_QDI_CLC_Challenger_Or54963_16x9_56810_Large-1200px-2-8.jpg
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Halifax:20240723T130000
DTEND;TZID=America/Halifax:20240723T140000
DTSTAMP:20260403T191745
CREATED:20240718T161933Z
LAST-MODIFIED:20241024T183050Z
UID:10000777-1721739600-1721743200@staging.digitalinsights.supremeclients.com
SUMMARY:Assessing drug safety with QIAGEN Biomedical KB-AI
DESCRIPTION:Are you a healthcare professional\, clinical researcher or data scientist interested in drug safety research? If so\, you know how vital understanding a drug’s adverse effects is to maximize its effect while minimizing its risks. This webinar will show how the QIAGEN Biomedical KB-AI knowledge graph can be used to explore scientific and pharmacovigilance data. Focusing on immune checkpoint inhibitors (ICIs)\, we will also demonstrate how Neo4j and Python can be combined to query\, visualize and analyze this data effectively. \nWe’ll cover the following: \n\nDrug safety profiling in Biomedical KB-AI\nPharmacovigilance case study of ICIs: Pembrolizumab\nComparative analysis of ICIs for comprehensive safety monitoring
URL:https://staging.digitalinsights.supremeclients.com/webinars-and-events/assessing-drug-safety-with-qiagen-biomedical-kb-ai/
LOCATION:Virtual - Americas - EST\, United States
CATEGORIES:Discovery,Webinar
ATTACH;FMTTYPE=image/jpeg:https://staging.digitalinsights.supremeclients.com/wp-content/uploads/2024/08/S_1212_8_QDI_QDI_BKB_Original_62142.jpg
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Halifax:20240723T130000
DTEND;TZID=America/Halifax:20240723T140000
DTSTAMP:20260403T191745
CREATED:20240808T095714Z
LAST-MODIFIED:20241024T182418Z
UID:10000555-1721739600-1721743200@staging.digitalinsights.supremeclients.com
SUMMARY:Assessing drug safety with QIAGEN Biomedical KB-AI
DESCRIPTION:Are you a healthcare professional\, clinical researcher or data scientist interested in drug safety research? If so\, you know how vital understanding a drug’s adverse effects is to maximize its effect while minimizing its risks. This webinar will show how the QIAGEN Biomedical KB-AI knowledge graph can be used to explore scientific and pharmacovigilance data. Focusing on immune checkpoint inhibitors (ICIs)\, we will also demonstrate how Neo4j and Python can be combined to query\, visualize and analyze this data effectively. \nWe’ll cover the following: \n\nDrug safety profiling in Biomedical KB-AI\nPharmacovigilance case study of ICIs: Pembrolizumab\nComparative analysis of ICIs for comprehensive safety monitoring
URL:https://staging.digitalinsights.supremeclients.com/webinars-and-events/assessing-drug-safety-with-qiagen-biomedical-kb-ai-2/
LOCATION:HSMD-screen-grab-2
ATTACH;FMTTYPE=image/jpeg:https://staging.digitalinsights.supremeclients.com/wp-content/uploads/2024/08/S_1212_8_QDI_QDI_BKB_Original_62142.jpg
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Halifax:20240724T130000
DTEND;TZID=America/Halifax:20240724T143000
DTSTAMP:20260403T191745
CREATED:20240618T122844Z
LAST-MODIFIED:20241024T183049Z
UID:10000776-1721826000-1721831400@staging.digitalinsights.supremeclients.com
SUMMARY:Checkpoint inhibitor and immuno-oncology investigation through OmicSoft Lands APIs
DESCRIPTION:While there is great interest in the scientific community to investigate drug targets and biomarkers from public immune-oncology data\, such investigation is hindered by the difficulty in finding and combining related datasets to perform large-scale meta-analyses. This webinar will focus on how high quality curated genomic repositories such as the QIAGEN OmicSoft Lands database immediately allows in-depth investigations across diverse data-sources (GEO\, CPTAC\, TCGA\, GTEx and many more) to discover and validate candidate checkpoint inhibitor drug targets and biomarker investigation. \nIn this webinar you will learn how to \n\nEasily identify relevant samples using extensive manually curated clinical metadata\nVisualize and identify checkpoint inhibition biology related drug target and biomarkers expression patterns in bulk and single cell RNA-seq studies.\nReveal how the expression of a group of biomarkers (or genes/proteins of interest) correlates in normal and disease tissue
URL:https://staging.digitalinsights.supremeclients.com/webinars-and-events/checkpoint-inhibitor-and-immuno-oncology-investigation-through-omicsoft-lands-apis/
LOCATION:Virtual - Americas - EST\, United States
CATEGORIES:Discovery,Webinar
ATTACH;FMTTYPE=image/jpeg:https://staging.digitalinsights.supremeclients.com/wp-content/uploads/2024/05/S_1052_1_QDI_OmicSoft_16x9.jpg
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Halifax:20240724T130000
DTEND;TZID=America/Halifax:20240724T143000
DTSTAMP:20260403T191745
CREATED:20240724T173808Z
LAST-MODIFIED:20241024T183054Z
UID:10000784-1721826000-1721831400@staging.digitalinsights.supremeclients.com
SUMMARY:IPA deep dive: miRNA investigation using QIAGEN Ingenuity Pathway Analysis (IPA)
DESCRIPTION:In this 90-minute training session\, you will learn how to identify target mRNAs for your miRNAs of interest and associate them with pathways\, diseases\, biological functions\, tissues and cell types. \nTopics that will be covered include: \n\nHow to analyze miRNA-seq datasets alone or both miRNA and corresponding mRNA datasets together\nHow to use QIAGEN IPA without a dataset\, using miRNA IDs\nIntroduction to databases and curated content specific to miRNA\nHow to effectively apply various filters and functionalities to identify biomarkers\, key targets and biological mechanisms\n\nLearn more about IPA or request for a trial.
URL:https://staging.digitalinsights.supremeclients.com/webinars-and-events/ipa-deep-dive-mirna-investigation-using-qiagen-ingenuity-pathway-analysis-ipa-2/
LOCATION:Virtual - Americas - EST\, United States
CATEGORIES:Discovery,Webinar
ATTACH;FMTTYPE=image/jpeg:https://staging.digitalinsights.supremeclients.com/wp-content/uploads/2024/08/S_1032_8_QDI_IPAlandExplorer_Gi1170740969_TME-training_promo_16x9.jpg
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Halifax:20240724T130000
DTEND;TZID=America/Halifax:20240724T143000
DTSTAMP:20260403T191745
CREATED:20240808T095715Z
LAST-MODIFIED:20241024T182418Z
UID:10000554-1721826000-1721831400@staging.digitalinsights.supremeclients.com
SUMMARY:Checkpoint inhibitor and immuno-oncology investigation through OmicSoft Lands APIs
DESCRIPTION:While there is great interest in the scientific community to investigate drug targets and biomarkers from public immune-oncology data\, such investigation is hindered by the difficulty in finding and combining related datasets to perform large-scale meta-analyses. This webinar will focus on how high quality curated genomic repositories such as the QIAGEN OmicSoft Lands database immediately allows in-depth investigations across diverse data-sources (GEO\, CPTAC\, TCGA\, GTEx and many more) to discover and validate candidate checkpoint inhibitor drug targets and biomarker investigation. \nIn this webinar you will learn how to \n\nEasily identify relevant samples using extensive manually curated clinical metadata\nVisualize and identify checkpoint inhibition biology related drug target and biomarkers expression patterns in bulk and single cell RNA-seq studies.\nReveal how the expression of a group of biomarkers (or genes/proteins of interest) correlates in normal and disease tissue
URL:https://staging.digitalinsights.supremeclients.com/webinars-and-events/checkpoint-inhibitor-and-immuno-oncology-investigation-through-omicsoft-lands-apis-2/
LOCATION:HSMD-screen-grab-2
ATTACH;FMTTYPE=image/jpeg:https://staging.digitalinsights.supremeclients.com/wp-content/uploads/2024/08/S_1052_1_QDI_OmicSoft_16x9-3.jpg
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Halifax:20240730T130000
DTEND;TZID=America/Halifax:20240730T140000
DTSTAMP:20260403T191745
CREATED:20240723T204754Z
LAST-MODIFIED:20241024T183050Z
UID:10000778-1722344400-1722348000@staging.digitalinsights.supremeclients.com
SUMMARY:Probing OncoLand using OmicSoft Studio
DESCRIPTION:There's more than one way to probe our OncoLand data. With the OmicSoft Studio graphical user interface (GUI)\, you won't need a script to fetch the data you want. This training will show how high-quality curated genomic repositories\, such as the QIAGEN OmicSoft Lands\, immediately allow in-depth investigations across diverse oncology and normal tissues/cells data sources (GEO\, CPTAC\, TCGA\, GTEx and many more) to discover and validate candidate checkpoint inhibitor drug targets and biomarker investigation. \nYou will learn to generate data for questions such as: \n\nHow is a gene (or a set of genes) expressed across different conditions (e.g.\, diseases\, treatments\, cell types)?\nHow is the expression of a gene correlated with the expression of other genes?\nFor a list of genes\, can we generate a heatmap studying their expression across different conditions?\nHow do you get a list of biomarkers specific to a condition from public studies?
URL:https://staging.digitalinsights.supremeclients.com/webinars-and-events/probing-oncoland-using-omicsoft-studio/
LOCATION:Virtual - Americas - EST\, United States
CATEGORIES:Discovery,Webinar
ATTACH;FMTTYPE=image/jpeg:https://staging.digitalinsights.supremeclients.com/wp-content/uploads/2024/08/S_1212_8_QDI_QDI_BKB_Original_62142.jpg
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Halifax:20240730T130000
DTEND;TZID=America/Halifax:20240730T140000
DTSTAMP:20260403T191745
CREATED:20240808T095713Z
LAST-MODIFIED:20241024T182419Z
UID:10000553-1722344400-1722348000@staging.digitalinsights.supremeclients.com
SUMMARY:Probing OncoLand using OmicSoft Studio
DESCRIPTION:There's more than one way to probe our OncoLand data. With the OmicSoft Studio graphical user interface (GUI)\, you won't need a script to fetch the data you want. This training will show how high-quality curated genomic repositories\, such as the QIAGEN OmicSoft Lands\, immediately allow in-depth investigations across diverse oncology and normal tissues/cells data sources (GEO\, CPTAC\, TCGA\, GTEx and many more) to discover and validate candidate checkpoint inhibitor drug targets and biomarker investigation. \nYou will learn to generate data for questions such as: \n\nHow is a gene (or a set of genes) expressed across different conditions (e.g.\, diseases\, treatments\, cell types)?\nHow is the expression of a gene correlated with the expression of other genes?\nFor a list of genes\, can we generate a heatmap studying their expression across different conditions?\nHow do you get a list of biomarkers specific to a condition from public studies?
URL:https://staging.digitalinsights.supremeclients.com/webinars-and-events/probing-oncoland-using-omicsoft-studio-2/
LOCATION:HSMD-screen-grab-2
ATTACH;FMTTYPE=image/jpeg:https://staging.digitalinsights.supremeclients.com/wp-content/uploads/2024/08/S_1212_8_QDI_QDI_BKB_Original_62142-1.jpg
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Halifax:20240801T130000
DTEND;TZID=America/Halifax:20240801T140000
DTSTAMP:20260403T191745
CREATED:20240723T210121Z
LAST-MODIFIED:20241024T183050Z
UID:10000779-1722517200-1722520800@staging.digitalinsights.supremeclients.com
SUMMARY:Discovery from sample-level public data (GEO\, SRA and more) using IPA Land Explorer
DESCRIPTION:Within QIAGEN Ingenuity Pathway Analysis (IPA)\, public data sourced from OmicSoft is already processed and standardized\, making it easy to jump to the actual research. In this training\, we'll show how to effectively use sample-level public data and metadata from sources like GEO\, SRA\, TCGA\, GTEx\, Blueprint\, CCLE and other sources using the IPA Analysis Match and Land Explorer features. We will walk through various use cases\, such as biomarker discovery\, drug target investigation\, studying survival in custom patient cohorts\, multi-gene correlation and more. \nYou will learn to answer questions such as: \n\nHow is a gene of interest expressed across different conditions (e.g. diseases\, treatments\, cell lines)?\nIs there correlation in the expression for two genes or biomarkers of user interest for a given condition?\nFor a given condition of interest\, can we derive a list of genes (e.g.\, genes specific to a disease\, treatment or cell type)?\nCan we generate custom cohorts of patients (e.g.\, example TP53 wt vs mutant or PDCD1 high vs low expression) and then\, generate survival curves representing those cohorts? Can we generate p-values to see if there is significant difference?\nCan we detect expression of a gene in different cell types from single cell data?
URL:https://staging.digitalinsights.supremeclients.com/webinars-and-events/discovery-from-sample-level-public-data-geo-sra-and-more-using-ipa-land-explorer/
LOCATION:Virtual - Americas - EST\, United States
CATEGORIES:Discovery,Webinar
ATTACH;FMTTYPE=image/jpeg:https://staging.digitalinsights.supremeclients.com/wp-content/uploads/2024/05/S_9978_QDI_IPA_Gi609807396_16x9_Medium-720px_50570.jpg
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Halifax:20240801T130000
DTEND;TZID=America/Halifax:20240801T140000
DTSTAMP:20260403T191745
CREATED:20240808T095712Z
LAST-MODIFIED:20241024T182420Z
UID:10000549-1722517200-1722520800@staging.digitalinsights.supremeclients.com
SUMMARY:Discovery from sample-level public data (GEO\, SRA and more) using IPA Land Explorer
DESCRIPTION:Within QIAGEN Ingenuity Pathway Analysis (IPA)\, public data sourced from OmicSoft is already processed and standardized\, making it easy to jump to the actual research. In this training\, we'll show how to effectively use sample-level public data and metadata from sources like GEO\, SRA\, TCGA\, GTEx\, Blueprint\, CCLE and other sources using the IPA Analysis Match and Land Explorer features. We will walk through various use cases\, such as biomarker discovery\, drug target investigation\, studying survival in custom patient cohorts\, multi-gene correlation and more. \nYou will learn to answer questions such as: \n\nHow is a gene of interest expressed across different conditions (e.g. diseases\, treatments\, cell lines)?\nIs there correlation in the expression for two genes or biomarkers of user interest for a given condition?\nFor a given condition of interest\, can we derive a list of genes (e.g.\, genes specific to a disease\, treatment or cell type)?\nCan we generate custom cohorts of patients (e.g.\, example TP53 wt vs mutant or PDCD1 high vs low expression) and then\, generate survival curves representing those cohorts? Can we generate p-values to see if there is significant difference?\nCan we detect expression of a gene in different cell types from single cell data?
URL:https://staging.digitalinsights.supremeclients.com/webinars-and-events/discovery-from-sample-level-public-data-geo-sra-and-more-using-ipa-land-explorer-2/
LOCATION:HSMD-screen-grab-2
ATTACH;FMTTYPE=image/jpeg:https://staging.digitalinsights.supremeclients.com/wp-content/uploads/2024/08/S_9978_QDI_IPA_Gi609807396_16x9_Medium-720px_50570-5.jpg
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Halifax:20240806T130000
DTEND;TZID=America/Halifax:20240806T150000
DTSTAMP:20260403T191745
CREATED:20240723T210538Z
LAST-MODIFIED:20241024T183052Z
UID:10000780-1722949200-1722956400@staging.digitalinsights.supremeclients.com
SUMMARY:QIAGEN Ingenuity Pathway Analysis (IPA) new user training
DESCRIPTION:Are you new to QIAGEN IPA or interested in expanding your skill set? Join us as we learn more on large dataset analysis and knowledge base queries using QIAGEN IPA. \nYou’ll learn how to: \n\nUpload multiple dataset types (e.g.\, RNA-seq\, proteomics\, metabolomics) and perform interactive core/pathway analysis in IPA\nLearn how to interpret different results\, including pathways\, key regulators\, impact on biological functions/diseases and more\nCompare different experimental conditions (e.g.\, single-cell clusters\, disease types) and identify similarities and contrasts\nGenerate a network for hypothesis generation\, even without a dataset or experimental design\n\nDo you already have an IPA license? Install IPA and start using it now. \nDon't have a license? Learn more about IPA or request a free trial.
URL:https://staging.digitalinsights.supremeclients.com/webinars-and-events/qiagen-ingenuity-pathway-analysis-ipa-new-user-training-3/
LOCATION:Virtual - Americas - EST\, United States
CATEGORIES:Discovery,Training
ATTACH;FMTTYPE=image/jpeg:https://staging.digitalinsights.supremeclients.com/wp-content/uploads/2024/05/S_9978_QDI_IPA_Gi609807396_16x9_Medium-720px_50570.jpg
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Halifax:20240808T130000
DTEND;TZID=America/Halifax:20240808T140000
DTSTAMP:20260403T191745
CREATED:20240723T210732Z
LAST-MODIFIED:20241024T183053Z
UID:10000781-1723122000-1723125600@staging.digitalinsights.supremeclients.com
SUMMARY:Sharing your analysis results with others in Ingenuity Pathway Analysis
DESCRIPTION:QIAGEN’s Ingenuity Pathway Analysis (IPA) is a powerful tool that allows you to upload your omics data and analyze it to identify key biological pathways and mechanisms and regulatory molecules. But did you know you can share your analysis results with others? In this 60-minute webinar\, we’ll explore the Share Manager and the Collaboration Workspace in IPA and go over the many ways you can share your analysis results with other or how they can share their results with you. \nAttendees will learn how to: \n\nShare datasets and analysis with other IPA users\nUse the Share with me feature\nEmail interactive pathways to other IPA users\nUse a Collaboration Workspace (CWS)
URL:https://staging.digitalinsights.supremeclients.com/webinars-and-events/sharing-your-analysis-results-with-others-in-ingenuity-pathway-analysis/
LOCATION:Virtual - Americas - EST\, United States
CATEGORIES:Discovery,Webinar
ATTACH;FMTTYPE=image/jpeg:https://staging.digitalinsights.supremeclients.com/wp-content/uploads/2024/05/S_9978_QDI_IPA_Gi609807396_16x9_Medium-720px_50570.jpg
END:VEVENT
END:VCALENDAR